About this event

  • Date and time Thu 23 Apr 2020 from 8:30am to 23 Apr 2020 at 5:30pm
  • Location Royal Society of Medicine
  • Organised by Pain Medicine

Over the past few months, concerns have been raised that a potential opioid crisis’ has hit the UK, following the release of a report by Public Health England. 

The figures show there is in fact little relationship between the UKs problem and the opioid crisis in the US, but the report did identify an issue around the overprescription of painkillers and other prescription medicines in the UK, along with growing levels of addiction among patients. 

Morning

The morning session will explore the extent of the painkiller overprescription problem in the UK, how it has come about, and what the key drivers are.

Attendees can expect to:

  • Understand the context of the painkiller overprescription issue, looking at the drugs that are involved, the data and trends, and the scale of the problem.  
  • Explore the various reasons why this issue has surfaced. 
  • Explore key issues by those actively involved - featuring representatives from public health, pain medicine and affected areas. 
  • Gain insight and potential takeaway solutions on how to tackle the problem, and what needs to change. 

Afternoon

The afternoon session will focus on the challenges for clinicians around opioid stewardship in the UKalternatives to prescription, and education (for patients as well as colleagues).

Attendees can expect to:

  • Recognise regional variation in the prescription of opioids. 
  • Understand the efficacy of opioids as well as explore alternative medication, in terms of both benefit and harm. 
  • Agree on best strategies to explain the opioid problem effectively to patients, as well as colleagues.

Please note, lunch is provided ONLY to delegates attending both morning and afternoon sessions.

Join in the conversation online
Follow us on Twitter: @RoySocMed

Tickets

Early bird pricing available until 02 February 2020.

Lunch is provided only to delegates attending both morning and afternoon sessions.

Member

RSM Fellow
Day 1
£69.00 Morning session (mandatory)
£25.00 Afternoon session
RSM Associate
Day 1
£30.00 Morning session (mandatory)
£25.00 Afternoon session
RSM Retired Fellow
Day 1
£30.00 Morning session (mandatory)
£25.00 Afternoon session
RSM Trainee
Day 1
£30.00 Morning session (mandatory)
£25.00 Afternoon session
RSM Student
Day 1
£18.00 Morning session (mandatory)
£15.00 Afternoon session

Non - Member

Consultant / GP
Day 1
£115.00 Morning session (mandatory)
£25.00 Afternoon session
AHP / Nurse / Midwife
Day 1
£50.00 Morning session (mandatory)
£25.00 Afternoon session
Non Healthcare Professional
Day 1
£50.00 Morning session (mandatory)
£25.00 Afternoon session
Trainee
Day 1
£50.00 Morning session (mandatory)
£25.00 Afternoon session
Student
Day 1
£30.00 Morning session (mandatory)
£15.00 Afternoon session

Key speakers

Yvonne Doyle

Medical Director, Public Health England

Speaker's biography

Yvonne Doyle is a qualified doctor and has worked in senior roles in the NHS and Department of Health and Social Care (DHSC), and in the academic and independent sectors. Between 2013 to 2019 she provided leadership for health and reduction of inequalities at city-wide level to the population of London and was Statutory Adviser to the Mayor of London.

In 2019 Yvonne was appointed Medical Director and Director of Health Protection for Public Health England.

Dr Jane Quinlan

Consultant in Pain Medicine

Speaker's biography

Jane studied medicine at St Thomas’s Hospital Medical School, London; trained in anaesthesia at St Thomas’s and St Bartholomew’s Hospitals before coming to Oxford in 1997; and was appointed consultant in 2000.

Her pain interests include opioid painkiller dependence; persisting post-surgical pain; and pain management in neuromyelitis optica.

Rosanna O’Connor

Director of Alcohol, Drugs, Tobacco and Justice at Public Health England

Speaker's biography

Rosanna O’Connor is Director, Alcohol, Drugs & Tobacco within the Health and Wellbeing Directorate of Public Health England (PHE). Rosanna was previously Director of Delivery at the National Treatment Agency for Substance Misuse (NTA). Having joined the NTA in 2003, she quickly assumed responsibility for all the agency’s operational activity.

Her interest in health inequalities of individuals and communities is based on extensive experience of local communities.

Professor Andrew Moore

Oxford University

Professor David Nutt

Imperial College

Speaker's biography

David completed his medical training at Guy's Hospital London, continuing in neurology to MRCP. 

After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. In 1988, he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET. 

Agenda

Morning Session 23 April 2020

Registration, tea and coffee
Welcome address

Session 1: Context and overview - what is the problem?

Overview of pain prescriptions in a broader population context

Yvonne Doyle, Medical Director at Public Health England

The perspective from GPs

Professor Mike Holmes, RCGP Vice-Chair of Membership and international

Panel discussion
Short break

Session 2: Exploration of key factors

Lived experience from patient - personal experience of prescription and addiction

Paul

Local view from affected area, and the multi-agency approach to tackle the problem

Dr Claire Bradford, Medical Director, NHS Sunderland Clinical Commissioning Group

Have patients got the message about the dangers of opioids?

Dr Jane Quinlan, Consultant anaesthetist, Oxford University Hospitals NHS Trust

The way forward - an overview of public health recommendations

Peter Burkinshaw, Alcohol and Drug Treatment and Recovery Lead, Public Health England

Panel discussion
Coffee break

Session 3: What needs to change?

Panel session and audience debate, with speakers from the day giving their thoughts on potential solutions for what needs to change, before opening the debate up to the audience and building an ‘action plan’ based around key takeaways.

Panel discussion
Close of the morning session

Full day delegates stay for lunch

Afternoon Session 23 April 2020

Session 1: Opioid stewardship

Lunch

Only for delegates that have booked both the morning and afternoon session

Consent and contract - legal implications of using opioids

TBC

Geographical variation in prescribing

Georgia Richards, Doctoral Researcher, University of Oxford

Pharmacy view of secondary care, post discharge meds

TBC

Panel discussion
Coffee break

Session 2: Evidence for efficacy of opioids and alternatives

Do opioids work?

Professor Andrew Moore, Director of Pain Research, Nuffield Department of Anaesthetics, University of Oxford

Alternatives - evidence for benefit as well as harm

Professor David Nutt, Faculty of MedicineDepartment of Brain Sciences, Imperial College London

Short break

Session 3: Solutions not problems: Education for all

Psychological complexity of patients

Dr Jane Quinlan, Consultant anaesthetist, Oxford University Hospitals NHS Trust

Training our colleagues

Dr Helen Makin, Faculty of Pain Medicine

Panel discussion

Featuring speakers from Session 2 & 3

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

PNN02 Promo
CPD

New developments in the pharmacological management of chronic pain: Problems and possibilities

Experts review the pharmacological targets for pain management and discuss the newest trends in chronic pain therapy, from drawing on cross species knowledge and the concept of using spontaneous disease models in animals to facilitate analgesic development in human medicine.

  • Price £27 - £145
  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Book Book
MBN02 Promo

Opioid exposure in pregnancy: Effects on mother, baby and beyond

This meeting will highlight the impact of opioid exposure to mothers and babies. From pre-pregnancy to birth, experts will cover all aspects of how to manage, support and safeguard these patients. 

  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
PNN03 Promo

Pain prehabilitation prior to surgery

Our multidisciplinary speakers will review the evidence as to whether changes in our diet, sleep, exercise regimen, pain medication, psychological preparation and managing our expectations can promote better outcomes.

  • Price £30 - £133
  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Book Book
PNN04 promo

Sleep and pain

Join us as we bring together experts from two separate faculties, pain and sleep medicine, to explore the bidirectional link between pain and sleep. 

  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Book Book